Armistice Capital »

Inogen shares owned by Armistice Capital

Quarter-by-quarter ownership of Inogen (INGN) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Inogen

Tip: Access up to 7 years of quarterly data

All positions including Inogen held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inogen by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.4M 1.2M 6.18
2025-09-30 $7.1M 864k 8.17

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Inogen

BlackRock
Vanguard Group
Armistice Capital
Acadian Asset Management
Vanguard Capital Management
Ameriprise Financial
DAFNA Capital Management
Point72 Asset Management
Geode Capital Management
Renaissance Technologies
Goldman Sachs Group
Morgan Stanley
Federated Investors
State Street Corporation
Dimensional Fund Advisors

View all funds holding Inogen